Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.
Part 2.1: Price Behavior Around Earnings
MEDP reports after market close, meaning Day 0 reflects anticipatory trading before results are released, while Day +1 captures the market's first full reaction to the actual earnings.
| Earnings Date | Day 0 Move | Day 0 Range | Day +1 Move | Day +1 Range |
|---|---|---|---|---|
| 2026-07-22 | -$3.55 (-0.67%) | $11.12 (2.09%) | +$77.70 (+14.71%) | $85.25 (16.14%) |
| 2026-04-22 | -$6.44 (-1.25%) | $23.98 (4.66%) | -$115.04 (-22.63%) | $34.61 (6.81%) |
| 2026-02-09 | -$11.69 (-2.16%) | $19.60 (3.62%) | -$84.30 (-15.90%) | $52.05 (9.81%) |
| 2025-10-22 | +$1.11 (+0.20%) | $20.62 (3.78%) | +$49.87 (+9.12%) | $48.76 (8.92%) |
| 2025-07-21 | -$2.99 (-0.96%) | $9.70 (3.11%) | +$168.85 (+54.67%) | $65.29 (21.14%) |
| 2025-04-21 | -$7.29 (-2.46%) | $11.44 (3.86%) | -$6.71 (-2.32%) | $35.32 (12.22%) |
| 2025-02-10 | +$0.41 (+0.12%) | $13.07 (3.69%) | -$26.65 (-7.52%) | $20.17 (5.69%) |
| 2024-10-21 | -$3.48 (-0.98%) | $13.80 (3.87%) | -$26.38 (-7.47%) | $28.47 (8.07%) |
| Avg Abs Move | 1.10% | 3.58% | 16.79% | 11.10% |
Historical price behavior around earnings shows extreme volatility, with an average absolute Day +1 move of 16.79% — significantly higher than typical for large-cap stocks. The most dramatic reaction came in July 2025, when the stock surged 54.67% the day after reporting, followed by a 22.63% decline after the April 2026 report and a 15.90% drop following February 2026 earnings.
More recently, the pattern has moderated somewhat. The July 2026 report produced a 14.71% gain on Day +1, while October 2025 saw a 9.12% advance. However, the Day 0 moves remain relatively muted (averaging just 1.10%), indicating that most price discovery occurs after results are digested.
The 11.10% average Day +1 range underscores the two-way risk, with investors facing substantial potential for both gains and losses depending on the quality of results and guidance. Given the stock's recent strength and elevated valuation multiples, the risk of a negative surprise reaction may be heightened if results or commentary disappoint.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 11/20/26 (DTE 31) |
| Expected Move | $40.63 (6.53%) |
| Expected Range | $581.39 to $662.65 |
| Implied Volatility | 62.67% |
The options market is pricing a 6.53% expected move through the November 20, 2026 expiration, implying a range of $581.39 to $662.65. This is substantially below the stock's average historical Day +1 move of 16.79%, suggesting options traders may be underpricing earnings volatility or that recent moves have been outliers. Investors should be prepared for price action that potentially exceeds the options-implied range.
Part 3: What Analysts Are Saying
Analyst sentiment on MEDP reflects cautious optimism, with a consensus rating of 3.21 (Hold) based on 14 analysts covering the stock. The breakdown shows 1 Strong Buy, 1 Moderate Buy, 12 Holds, and no sell ratings, indicating that while analysts see value in the business model, most are taking a wait-and-see approach at current valuation levels.
The average price target of $616.46 implies essentially flat performance from the current price of $622.43, representing just -0.96% downside. However, the range of targets is wide: the high estimate of $700.00 suggests +12.47% upside for bulls, while the low target of $492.00 implies -20.95% downside for bears. This dispersion reflects genuine disagreement about the stock's fair value.
Sentiment has deteriorated over the past month, with the number of Hold ratings increasing from 11 to 12 while the average recommendation slipped slightly from 3.23 to 3.21. This subtle shift suggests some analysts are growing more cautious, possibly due to valuation concerns as the stock has appreciated 19.09% over the past 52 weeks and trades at a forward P/E of 34.37 — a premium multiple that leaves little room for disappointment.
Part 4: Technical Picture
MEDP enters earnings with strong technical momentum, as the Barchart Technical Opinion shows a 100% Buy signal, strengthening from 88% Buy last week and matching the 100% reading from a month ago. This improvement reflects the stock's ability to hold gains and build on its uptrend heading into the report.
Timeframe Analysis:
- Short-term (100% Buy): Strong buy signal indicates robust near-term momentum with buyers in control
- Medium-term (100% Buy): Continued strength in the intermediate timeframe suggests the uptrend is well-established
- Long-term (100% Buy): Bullish long-term signal confirms the broader trend remains positive across all time horizons
Trend Characteristics: The Strong trend with Strengthening direction indicates MEDP is in a powerful uptrend with improving momentum, providing a supportive technical backdrop for the earnings release.
The stock is trading above all major moving averages, including the 5-day ($621.16), 10-day ($615.47), 20-day ($614.73), 50-day ($607.38), 100-day ($565.09), and 200-day ($526.72). This alignment with the current price of $622.43 above every key average is a textbook bullish setup, showing consistent buying pressure across multiple timeframes.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $621.16 | 50-Day MA | $607.38 |
| 10-Day MA | $615.47 | 100-Day MA | $565.09 |
| 20-Day MA | $614.73 | 200-Day MA | $526.72 |
The Relative Strength Index of 57.82 indicates the stock is in neutral territory — neither overbought nor oversold — leaving room for further upside on positive results without suggesting the rally is exhausted. The 50-day moving average at $607.38 provides nearby support, while the stock's position near recent highs means there's limited technical resistance overhead. However, the premium valuation and strong pre-earnings run create a challenging setup: while the technical picture is supportive, the stock may need exceptional results and guidance to justify further gains, and any disappointment could trigger profit-taking from a well-positioned investor base.